Overview and Scope
Anastomosis devices are disposable or reusable instruments that establish an inverted or everted tissue closure secured by two or more rows of B-shaped stainless steel, titanium, or occasionally absorbable staples. It used to remove tissues that are diseased in the body without the leakage of body fluids.
Sizing and Forecast
The anastomosis devices market size has grown strongly in recent years. It will grow from $3.49 billion in 2023 to $3.76 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing surgical procedures, growing aging population, prevalence of chronic diseases, improvements in healthcare infrastructure, awareness and education.
The anastomosis devices market size is expected to see strong growth in the next few years. It will grow to $4.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising global healthcare expenditure, expansion of minimally invasive surgeries, advancements in anastomosis device designs, focus on patient outcomes, global increase in chronic diseases. Major trends in the forecast period include focus on patient outcomes and quality of life, development of anastomosis sealants, prevalence of colorectal diseases, global aging population, collaborations and partnerships.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/anastomosis-devices-global-market-report
Segmentation & Regional Insights
The anastomosis devices market covered in this report is segmented –
1) By Type: Surgical Staplers, Surgical Stutures, Surgical Sealants and Adhesives, Automated Suturing
2) By Usage: Disposable, Reusable
3) By Application: Cardiovascular And Thoracic Surgery, Gastrointestinal Surgery, Orthopedic Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgery Centers, Other End-Users
North America was the largest region in the anastomosis devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global anastomosis devices market report during the forecast period. The regions covered in the anastomosis devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10558&type=smp
Major Driver Impacting Market Growth
The growth in surgical procedures is expected to propel the anastomosis device market going forward. Surgical procedures refer to any medical practice in which an incision is made on a person’s body. Anastomosis devices are used mainly for surgical procedures to connect two body portions, such as the blood vessels or intestines. For instance, in April 2022, according to the American Society for Aesthetic Plastic Surgery, a US-based organization for plastic surgery and cosmetic medicine, among the data collected from 294 participating plastic surgery practices, Surgical operations climbed 54%, and non-surgical procedures increased by 44%. Further, according to the American Society of Plastic Surgeons, a US-based plastic surgery specialty organization, 6.8 million reconstructive procedures were performed, a 3% increase from 2019. Therefore, the growth in surgical procedures will drive the anastomosis device market.
Key Industry Players
Major companies operating in the anastomosis devices market report are Medtronic plc, Synvisc Micro Companies Alliance Inc., B. Braun Melsungen AG, Novare Surgical Systems Inc., Dextera Surgical Inc., Intuitive Surgical Inc., Boston Scientific Corp., Artivion Inc., Johnson & Johnson Services Inc., Röchling Group, Bluesail Surgical, Vascular Graft Solutions Ltd., Baxter International Inc., LivaNova plc, Getinge AB, Meril Life Sciences Pvt. Ltd., Becton, Dickinson and Company, Terumo Corporation, Teleflex Incorporated, Scanlan International Inc., Microline Surgical Inc., Grena Ltd., CryoLife Inc., Cardica Inc., Stryker Corporation, LifeNet Health Inc., Jotec GmbH, JenaValve Technology Inc., Innovia Medical, Genesee BioMedical Inc., EndoEvolution LLC, Edwards Lifesciences Corporation, ConMed Corporation, Cardialen Inc.
The anastomosis devices market report table of contents includes:
1. Executive Summary
2. Anastomosis Devices Market Characteristics
3. Anastomosis Devices Market Trends And Strategies
4. Anastomosis Devices Market – Macro Economic Scenario
5. Global Anastomosis Devices Market Size and Growth
….
31. Global Anastomosis Devices Market Competitive Benchmarking
32. Global Anastomosis Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Anastomosis Devices Market
34. Anastomosis Devices Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
